Macular Degeneration Treatment Global Market Report 2022: Increasing Burden of Retinal Disorders to Bolster Sector Growth – ResearchAndMarkets.com

by Business Wire • 2022/09/09 • 0 Comments

DUBLIN--(BUSINESS WIRE)--The "Macular Degeneration Treatment Market Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering. The global macular degeneration treatment market is expected to grow from $7.55 billion in 2021 to $8.08 billion in 2022 at a compound annual growth rate (CAGR) of 7.04%. The market is expected to reach $10.65 billion in 2026 at a CAGR of 7.15%. In 2021, North America will be the largest region in the macular degeneration treatment market. As

← NovaBay Pharmaceuticals Enters Into Agreements For a Private Placement and Warrant Reprice Transactions To Raise Up to $5.3 Million

No differences found for bevacizumab in retinal vein occlusion across racial groups →

Post navigation